Gestational diabetes & diabetes in pregnancy
Plasma Glycated Albumin in Early Pregnancy and Gestational Diabetes Mellitus: A Prospective and Longitudinal Study
Authors' conclusion
This study suggests that GA concentrations in midpregnancy might be lower in women who later develop GDM. Further studies are needed to identify the mechanism.
Study context
- Population
- Pregnant women in the NICHD Fetal Growth Study; Glycated albumin (GA) measured at 10–14 and 15–26 weeks' gestation
- Participants
- 107 vs 214
- Comparison
- Gestational diabetes mellitus (GDM) cases vs controls
- GDMn = 107
- Controln = 214reference
- Outcome
- GA concentrations and GDM risk
Methodological detailslongitudinal
- Longitudinal
Main finding
As reported in the abstract
Mean GA · 15-26 weeks' gestation
Adjusted P value for difference = 0.004
Observational data: associations, not effects.
Further findings
GA concentrations and GDM risk
- Higher GA tended to have lower GDM risk; associations not statistically significant
Original publication
Plasma Glycated Albumin in Early Pregnancy and Gestational Diabetes Mellitus: A Prospective and Longitudinal Study. Diabetes Care. Published 5 July 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →